title: Aclacinomycin, cytosine arabinoside and thioguanine in relapsed or resistant acute myeloid leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Neri
authors.forename: M
authors.initials: M
authors.lastname: Comis
authors.forename: M
authors.initials: M
authors.lastname: Brugiatelli
authors.forename: B
authors.initials: B
authors.lastname: Martino
authors.forename: F
authors.initials: F
authors.lastname: Ronco
mesh_terms: D015250:Aclarubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: C011157:aclacinomycins; D003561:Cytarabine; D015250:Aclarubicin; D013866:Thioguanine